Figure 8

![Figure 8: Preclinical outcomes of curcumin-loaded nanoparticles in Alzheimer's animal models are summarized, showing improved cognitive outcomes and reduced amyloid burden.]()

> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)

<figure>
  <img src="" alt="Preclinical outcomes of curcumin-loaded nanoparticles in Alzheimer's animal models are summarized, showing improved cognitive outcomes and reduced amyloid burden." />
  <figcaption>Figure 8. Preclinical outcomes of curcumin-loaded nanoparticles in Alzheimer's animal models are summarized, showing improved cognitive outcomes and reduced amyloid burden.<br>  Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption>
</figure>